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In isolated rat liver perfused at constant pressure with Krebs-Henseleit buffer containing 5 mM glucose, 
2 mM lactate, 0.2 mM pyruvate and 0.1% bovine serum albumin, perivascular nerve stimulation (20 V, 20 
Hz, 2 ms) and infusion of ATP (100 PM), noradrenaline (1 PM) or arachidonic acid (100 PM) caused an 
increase in glucose and lactate output and a reduction of perfusion flow. The metabolic effects of nerve 
stimulation but not those of ATP and noradrenaline were inhibited strongly by the phospholipase AZ inhibi- 
tor bromophenacyl bromide (BPB, 20 ,uM) and the cyclooxygenase inhibitor indomethacin (Indo, 20 PM) 
and only slightly by the lipoxygenase inhibitor nordihydroguaiaretic acid (NDGA, 20 PM). In contrast, the 
hemodynamic effects not only of nerve stimulation but also of ATP and noradrenaline were inhibited 
strongly by BPB and Indo and slightly by NDGA. The metabolic and hemodynamic actions of arachidonate 
were inhibited specifically by Indo. These results suggest that the effects of nerve stimulation were at least 
partially mediated or modulated by eicosanoids, especially by prostanoids. 
Noradrenaline; extracellular ATP; Icosanoid; Arachtdonic acid; (Perfused rat liver, Sympathetic hepatic nerve) 
1. INTRODUCTION 
The liver is innervated by sympathetic and para- 
sympathetic, afferent and efferent nerves [l-4]. In 
isolated rat liver perfused in situ stimulation of 
perivascular nerve bundles was shown to cause an 
increase in glucose and lactate output [5] as well as 
urate and allantoin formation [6], reduction of 
ketogenesis [7], urea release and ammonia uptake 
[8] as well as oxygen utilization [9,10], decrease as 
well in intrahepatic redistribution of flow [5,9,22], 
overflow of noradrenaline into the hepatic vein 
[l 11, and transient increase of calcium efflux and 
potassium uptake [12]. The nerve effects could be 
caused indirectly via hemodynamic changes or nor- 
adrenaline overflow from the vasculature into the 
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sinusoids or directly by neurotransmitter release 
within nerve contacts with (almost) each hepato- 
cyte or with only some periportal hepatocytes and 
signal propagation via gap junctions (cf. fig.5 in 
[5]). Evidence for a direct mode of nerve action has 
recently been presented [ 131. Since in rat liver the 
parenchymal and non-parenchymal cells were 
found to be innervated [14], the possibility was 
considered that the nerve action might be mediated 
at least partially or modulated by eicosanoids, 
which are produced only in the sinusoidal cells, 
such as Kupffer and endothelial cells [ 15,161. 
Here, the metabolic and hemodynamic effects 
caused by nerve stimulation, ATP, noradrenaline 
and arachidonic acid were studied in the presence 
of bromophenacyl bromide (BPB), an inhibitor of 
arachidonate formation from phospholipids [ 171, 
(lndo), an inhibitor of prostanoid synthesis [18], 
and nordihydroguaiaretic acid (NDGA), an in- 
hibitor of leukotriene production [19]. The results 
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allow one to conclude that in rat liver non- 
parenchymal cells play a mediator or modulator 
role in the metabolic actions of hepatic nerves. 
2. MATERIALS AND METHODS 
adrenaline and arachidonic acid were infused, 
reaching final concentrations as indicated in the 
figures. Arachidonic acid was dissolved in the per- 
fusion medium enriched with 10% BSA; this mix- 
ture was sonicated for 2-3 min before infusion. 
2.1 . Materials 2.5. Determination of metabolites and 
All chemicals were of reagent grade and from 
commercial sources. Enzymes, bovine serum 
albumin (BSA) and adenosine 5 ‘-triphosphate 
(ATP) were purchased from Boehringer (Mann- 
heim). Noradrenaline bitartrate was from Serva 
(Heidelberg). Indo, NDGA and dimethyl sulfoxide 
(DMSO) were from Sigma (Deisenhofen). 
noradrenaline 
Metabolites were measured with standard en- 
zymatic techniques [20]. Noradrenaline was quan- 
titated radiochemically after enzymatic methyla- 
tion with S-[3H]adenosylmethionine, conversion to 
[3H]normethanephrine and separation by thin- 
layer chromatography [ 111. 
2.2. Animals 
Male Wistar rats (150-200 g) were obtained 
from Winkelmann (Borchen). At least 1 week 
before experiments, they were subjected to a 12 h 
day-night rhythm with free access to food (stan- 
dard diet 1320 of Altromin, Lage). All experiments 
were started between 9 and 12 a.m. Animals were 
anaesthetized by intraperitoneal injection of pen- 
tobarbital (60 mg/kg body wt). 
3. RESULTS 
3.1. Influence of nerve stimulation, A TP, 
noradrenaline and arachidonate on 
carbohydrate metabolism and 
hemodynamics 
Electrical nerve stimulation (20 V, 20 Hz, 2 ms; 
2.3. Liver perfusion 
The liver was perfused in situ without recircula- 
tion via the portal vein in a 37°C cabinet as in [5]. 
Perfusion was started with erythrocyte-free Krebs- 
Henseleit bicarbonate buffer containing 5 mM 
glucose, 2 mM lactate and 0.2 mM pyruvate. At 20 
min before the first stimulus, the perfusion 
medium was enriched with 0.1% BSA and, where 
indicated, with inhibitors of eicosanoid synthesis. 
BPB, Indo and NDGA were dissolved first in 
DMSO (concentration approx. 33 mM for each in- 
hibitor) and then added slowly to the perfusion 
medium containing 0.1% BSA, reaching final con- 
centrations as indicated in the figures. Perfusion 
pressure was constant at about 10 cmHz0 with a 
flow rate of 3.9-4.1 ml. min-’ . g-’ liver under 
basal conditions. 
which was sufficient to cause maximal effect [21]) 
resulted in an increase in glucose and lactate out- 
put, and a decrease of flow, reaching a maximum 
at about 3 and 2 min, respectively; these changes of 
substrate balance and flow then began to return to 
the pre-stimulation level in spite of continued 
stimulation indicating an ‘escape’ phenomenon 
[22] (fig. 1). 
2.4 Nerve stimulation and infusion of signal 
compounds 
The hepatic nerves were stimulated with a bi- 
polar platinum wire electrode placed perivascularly 
around both the portal vein and hepatic artery 
which was not perfused but was still joined to the 
portal vein (20 V, 20 Hz, 2 ms). ATP, nor- 
Infusion of ATP (100 PM), which is a consti- 
tuent of noradrenaline-containing vesicles of sym- 
pathetic nerve terminals [23], as well as infusion of 
noradrenaline (1 PM), which is the typical sym- 
pathetic neurotransmitter, mimicked the nerve ac- 
tions; they also caused a remarkable increase in 
glucose and lactate output and a reduction of flow. 
With ATP the peak values of both metabolic and 
hemodynamic responses were higher yet also more 
retarded than those of nerve stimulation. Flow 
reduction showed a recovery during continued 
ATP infusion, i.e. an escape phenomenon (fig.1). 
With noradrenaline the peak value of the 
metabolic response was similar to and those of the 
hemodynamic changes smaller than the effects of 
nerve stimulation (fig. 1). Arachidonic acid (100 
PM), the precursor of eicosanoid synthesis, caused 
a qualitatively similar, yet clearly smaller response 
than the other stimuli (fig.1). 
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Fig. 1. Glucose and lactate balance and perfusion flow in 
perfused rat liver following perivascular nerve stimula- 
tion and ATP, noradrenaline and arachidonate infusion. 
Livers were perfused m situ without recirculation via the 
portal vein with erythrocyte-free media containing 
5 mM glucose, 2 mM lactate and 0.2 mM pyruvate. The 
nerve plexus around the portal vein and hepatic artery 
was stimulated (20 V, 20 Hz, 2 ms; NS), then ATP 
(lOOpM), noradrenaline (1 PM, NA) and arachidonate 
(lOOpM, Ara) were infused. Values are means k SE of 
3 separate determinations each. 
3.2. Effect of inhibitors of eicosanoid synthesis 
on the metabolic changes caused by the 
various stimuli 
The liver was perfused with inhibitors of eico- 
sanoid synthesis 20 min prior to the first stimula- 
tion. BPB, a phospholipase AZ inhibitor [17], 
suppressed the increase in glucose output caused 
by nerve stimulation, measured as the area under 
the curve, remarkably by almost 80%. Indo, a 
cyclooxygenase inhibitor [18], and NDGA, a 
lipoxygenase inhibitor [ 191, also inhibited glucose 
output after nerve stimulation by about 70 and 
40070, respectively. Only BPB and not Indo or 
NDGA reduced lactate output significantly by 
about 60% (fig.2). The effects of ATP on glucose 
output were partially suppressed by the inhibitors, 
whereas those on lactate balance remained 
unaltered (fig.2). The metabolic effects of 
noradrenaline were not significantly influenced by 
the inhibitors (fig.2). On the other hand, 
arachidonic acid-induced metabolic changes were 
inhibited specifically and almost completely by In- 
do but not by BPB or NDGA (fig.2). 
3.3. Effect of inhibitors of eicosanoid synthesis 
on the hemodynamic hanges caused by the 
various stimuli 
The decrease of flow caused by nerve stimula- 
tion, measured as the area under the curve, was 
suppressed significantly with BPB by about 85% 
and with Indo by about 45%. The ATP-induced 
flow change was reduced with the inhibitors par- 
tially by about 50%. The hemodynamic effect of 
noradrenaline was also inhibited by the inhibitors, 
yet only the inhibition with BPB by about 65% was 
statistically significant. The hemodynamic effects 
of arachidonic acid were inhibited specifically by 
Indo, but not by BPB or NDGA. 
Fig.2. Effect of inhibitors of eicosanoid synthesis on the 
alterations of glucose and lactate balance in perfused rat 
liver induced by perivascular nerve stimulation and 
ATP, noradrenaline and arachidonate infusion. Livers 
were perfused as in fig.1. BPB, Indo and NDGA were 
added to the media at final concentrations of 20pM 
each 20 min before the onset of nerve stimulation (NS), 
which preceded the infusions of ATP, then nor- 
adrenaline (NA) and finally arachidonate (Ara). Altera- 
tions are expressed as the areas under the curve (AUC) 
in pmol. g- ‘. Values are means +- SE of 3 perfusions 
each. 
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Fig.3. Effect of inhibitors of eicosanoid synthesis on the 
decrease of perfusion flow in perfused rat liver induced 
by perivascular nerve stimulation and ATP, nor- 
adrenaline and arachidonate infusion. Livers were per- 
fused as in fig.1; the inhibitors BPB, Indo and NDGA 
were added and the stimuli applied as in fig.2. Altera- 
tions are expressed as the areas under the curve (AUC) 
in ml.g-‘. Values are means k SE of 3 perfusions each. 
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Fig.4. Noradrenaline overflow into the hepatic vein in- 
duced by perivascular nerve stimulation with or without 
inhibitors of eicosanoid synthesis. Livers were perfused 
as in fig.1; the inhibitors BPB, Indo and NDGA were 
added and the nerves stimulated as in fig.2. Nor- 
adrenaline was determined in the effluent before, during 
and after nerve stimulation. Values are means -t SE of 
3 perfusions each. 
3.4. Noradrenaline overflow during nerve 
stimulation 
In order to determine whether the inhibitors of 
eicosanoid synthesis suppressed the nerve action by 
blocking noradrenaline release from the nerve ter- 
minals, noradrenaline overflow into the effluent 
was measured during nerve stimulation with or 
without inhibitors. Noradrenaline overflow was 
not significantly influenced by any of the in- 
hibitors (fig.4). 
4. DISCUSSION 
It has been shown here with perfused rat liver 
that: (i) inhibitors of eicosanoid biosynthesis 
strongly inhibit the increase in glucose and lactate 
release caused by hepatic nerve stimulation, but 
only slightly so or not at all that caused by extra- 
cellular ATP and noradrenaline; and (ii) the in- 
hibitors reduced the decrease of perfusion flow 
elicited by nerve stimulation, ATP and nor- 
adrenaline (figs 2,3). 
4.1. Comparison of the effects of nerve 
stimulation with those of ATP and 
noradrenaline 
Stimulation of the hepatic nerve plexus in per- 
fused rat liver was previously shown to cause pre- 
dominantly sympathetic effects mediated via 
cu-receptors [4,5]. Therefore, the nerve effects were 
compared to the actions of noradrenaline, the ac- 
cepted sympathetic neurotransmitter, and of ATP, 
a possible sympathetic ‘cotransmitter’ [23]. In per- 
fused liver noradrenaline has been shown previous- 
ly to increase glucose and lactate output and to 
decrease perfusion flow under an enforced con- 
stant pressure [5-71 or to increase portal pressure 
at constant flow [lo]; similarly, ATP has been 
reported to increase glucose output and portal 
pressure [24,25]. 
In the present study, ATP and noradrenaline in- 
fusion caused qualitatively similar changes to 
nerve stimulation; however, the kinetics and extent 
of the changes were different (fig.1). Apparently, 
infusion of the accepted neurotransmitter nor- 
adrenaline and of the putative cotransmitter ATP 
could not mimick the nerve actions exactly. 
4.2. Eicosanoids as possible mediators or 
modulators of nerve action 
In isolated rat liver both the metabolic and 
hemodynamic effects caused by nerve stimulation 
were inhibited by BPB, Indo and NDGA, in- 
hibitors of eicosanoid synthesis (figs 2,3). The 
finding that noradrenaline overflow after nerve 
stimulation was not influenced by these inhibitors 
(fig.4) indicated that they did not inhibit the nerve 
function unspecifically but that they acted primari- 
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ly as inhibitors of eicosanoid synthesis. Since the 
inhibitory effects of the cyclooxygenase inhibitor 
Indo were greater than those of the lipoxygenase 
inhibitor NDGA, and arachidonic acid-induced 
changes were specifically inhibited by Indo, 
prostaglandins and/or thromboxanes might be 
more important than leukotrienes as mediators or 
modulators of nerve action. If, as appears to be ac- 
cepted [15,16], eicosanoids can be formed in the 
liver only by non-parenchymal rather than by 
parenchymal cells, the results of the present study 
indicate that the endothelial and Kupffer cells of 
the sinusoids play an important role as mediator 
and/or modulator cells for sympathetic nerve ac- 
tions on liver metabolism and hemodynamics. 
Since noradrenaline overflow from the nerve end- 
ings was not altered by the inhibitors (fig.4), it ap- 
pears that eicosanoids did not act on the nerve cells 
[26] but on parenchymal liver cells. 
Since the metabolic effects of ATP were slightly 
inhibited and the hemodynamic effects clearly in- 
hibited by the inhibitors (figs 2,3), it may be con- 
cluded that eicosanoids could also be involved as 
mediators or modulators of ATP action. With 
respect to metabolic changes, such a function can 
be expected to be less important, since ATP has 
been reported to act on parenchymal cells directly 
[27-301. 
The finding that the metabolic effects of nor- 
adrenaline were not affected by the inhibitors, 
while the hemodynamic actions were clearly re- 
duced (figs 2,3), indicates that eicosanoids may 
play a role in the control of liver blood flow but 
not of metabolism by circulating noradrenaline. 
A role of eicosanoids in the regulation of liver 
functions was suggested previously for the action 
in isolated perfused liver of platelet-activating fac- 
tor on glycogenolysis [31], of zymosan on portal 
pressure [32] and of heat-aggregated immuno- 
globulin G on glycogenolysis and portal pressure 
[33]. A possible involvement of eicosanoids in 
nerve action was also indicated by the finding in 
anaesthetized rabbits in vivo that glycogen phos- 
phorylase activation by preganglionic stimulation 
of the splanchnic, rather than by postganglionic 
stimulation of the hepatic nerves, was inhibited by 
intraperiportal infusion of Indo [34]. Since prosta- 
glandins of the E series were shown to inhibit 
glucagon-stimulated glycogenolysis and CAMP 
formation [35,36], the possibility has to be con- 
sidered that prostaglandins of the F series or 
thromboxanes may be involved in mediating 
metabolic nerve action. 
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